Atlas Trials

Fludarabine, Velcade and Rituximab for Relapsed or Refractory Follicular Non-Hodgkin Lymphoma

Clinical trial NCT01186458 · TERMINATED

Trial details

NCT number
NCT01186458
Sponsor
Hoosier Cancer Research Network
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Lymphoma, Non-Hodgkin
Start date
2010-10-01
Primary completion
2013-10-01
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.